20
Teva Pharmaceutical Industries Ltd Tel Aviv - Jaffa Il, based in Israel, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Teva API has over 350 products in its portfolio and is the leading international supplier of APIs.
One of their significant offerings is Olmesartan medoxomil, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2012-170 - Rev 01
This Chemical Type CEP, issued on May 25, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2600 associated with this CEP further emphasizes